Plerixafor, a small-molecule antagonist of CXCR4, is widely used to mobilize hematopoietic stem cells for autologous transplantation in non-Hodgkin's lymphoma and multiple myeloma (38). This evidence concerns the gene CXCR4 and AL amyloidosis.